| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glycogen phosphorylase activity | 7.94e-06 | 3 | 33 | 2 | GO:0008184 | |
| GeneOntologyMolecularFunction | 1,4-alpha-oligoglucan phosphorylase activity | 2.64e-05 | 5 | 33 | 2 | GO:0004645 | |
| GeneOntologyMolecularFunction | nuclear vitamin D receptor binding | 3.99e-04 | 18 | 33 | 2 | GO:0042809 | |
| GeneOntologyMolecularFunction | AMP binding | 5.45e-04 | 21 | 33 | 2 | GO:0016208 | |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 1.44e-03 | 34 | 33 | 2 | GO:0046966 | |
| GeneOntologyCellularComponent | mediator complex | 2.68e-05 | 37 | 33 | 3 | GO:0016592 | |
| GeneOntologyCellularComponent | vesicle tethering complex | 1.98e-04 | 72 | 33 | 3 | GO:0099023 | |
| Domain | Glyco_trans_35 | 9.07e-06 | 3 | 33 | 2 | IPR000811 | |
| Domain | PHOSPHORYLASE | 9.07e-06 | 3 | 33 | 2 | PS00102 | |
| Domain | Phosphorylase | 9.07e-06 | 3 | 33 | 2 | PF00343 | |
| Domain | Glycg_phsphrylas | 9.07e-06 | 3 | 33 | 2 | IPR011833 | |
| Domain | - | 4.79e-03 | 391 | 33 | 4 | 2.30.29.30 | |
| Domain | Olfact_rcpt | 4.88e-03 | 393 | 33 | 4 | IPR000725 | |
| Domain | GPCR_Rhodpsn_7TM | 6.04e-03 | 670 | 33 | 5 | IPR017452 | |
| Domain | 7tm_1 | 6.31e-03 | 677 | 33 | 5 | PF00001 | |
| Domain | PH_dom-like | 6.47e-03 | 426 | 33 | 4 | IPR011993 | |
| Domain | Ca/CaM-dep_Ca-dep_prot_Kinase | 6.60e-03 | 69 | 33 | 2 | IPR020636 | |
| Domain | G_PROTEIN_RECEP_F1_1 | 6.62e-03 | 685 | 33 | 5 | PS00237 | |
| Domain | G_PROTEIN_RECEP_F1_2 | 6.87e-03 | 691 | 33 | 5 | PS50262 | |
| Domain | GPCR_Rhodpsn | 6.91e-03 | 692 | 33 | 5 | IPR000276 | |
| Domain | PH | 7.57e-03 | 229 | 33 | 3 | PF00169 | |
| Domain | PH | 1.28e-02 | 278 | 33 | 3 | SM00233 | |
| Domain | PH_DOMAIN | 1.29e-02 | 279 | 33 | 3 | PS50003 | |
| Domain | PH_domain | 1.31e-02 | 280 | 33 | 3 | IPR001849 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION | 9.93e-05 | 9 | 24 | 2 | M47621 | |
| Pathway | BIOCARTA_FEEDER_PATHWAY | 9.93e-05 | 9 | 24 | 2 | M3061 | |
| Pathway | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | 2.50e-04 | 14 | 24 | 2 | MM15391 | |
| Pathway | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | 2.50e-04 | 14 | 24 | 2 | M19193 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 3.77e-04 | 84 | 24 | 3 | M1008 | |
| Pathway | REACTOME_GLYCOGEN_METABOLISM | 4.18e-04 | 18 | 24 | 2 | MM15577 | |
| Pathway | REACTOME_RSV_HOST_INTERACTIONS | 5.93e-04 | 98 | 24 | 3 | M48247 | |
| Pathway | REACTOME_GLYCOGEN_METABOLISM | 8.14e-04 | 25 | 24 | 2 | M27857 | |
| Pathway | REACTOME_ADIPOGENESIS | 8.30e-04 | 110 | 24 | 3 | M48259 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 1.02e-03 | 118 | 24 | 3 | M27316 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY | 1.07e-03 | 120 | 24 | 3 | M48233 | |
| Pathway | WP_GLYCOGEN_METABOLISM | 1.51e-03 | 34 | 24 | 2 | MM15985 | |
| Pathway | WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION | 2.08e-03 | 40 | 24 | 2 | M39595 | |
| Pubmed | 3.44e-06 | 31 | 33 | 3 | 23322298 | ||
| Pubmed | 1.23e-05 | 47 | 33 | 3 | 15175163 | ||
| Pubmed | Genome-wide association study of the rate of cognitive decline in Alzheimer's disease. | 1.77e-05 | 53 | 33 | 3 | 23535033 | |
| Pubmed | 2.44e-05 | 8 | 33 | 2 | 23749998 | ||
| Pubmed | Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex. | 3.13e-05 | 9 | 33 | 2 | 8710870 | |
| Pubmed | 3.13e-05 | 9 | 33 | 2 | 14636573 | ||
| Pubmed | 3.88e-05 | 407 | 33 | 5 | 12693553 | ||
| Pubmed | Trait-associated noncoding variant regions affect TBX3 regulation and cardiac conduction. | 3.91e-05 | 10 | 33 | 2 | 32672536 | |
| Pubmed | A coregulatory role for the TRAP-mediator complex in androgen receptor-mediated gene expression. | 3.91e-05 | 10 | 33 | 2 | 12218053 | |
| Pubmed | HIF1A employs CDK8-mediator to stimulate RNAPII elongation in response to hypoxia. | 3.91e-05 | 10 | 33 | 2 | 23746844 | |
| Pubmed | Human mediator subunit MED26 functions as a docking site for transcription elongation factors. | 4.63e-05 | 73 | 33 | 3 | 21729782 | |
| Pubmed | Transcription coactivator TRAP220 is required for PPAR gamma 2-stimulated adipogenesis. | 4.78e-05 | 11 | 33 | 2 | 12037571 | |
| Pubmed | 5.64e-05 | 78 | 33 | 3 | 25720964 | ||
| Pubmed | 6.02e-05 | 225 | 33 | 4 | 12168954 | ||
| Pubmed | CDK8 is a positive regulator of transcriptional elongation within the serum response network. | 6.77e-05 | 13 | 33 | 2 | 20098423 | |
| Pubmed | A novel docking site on Mediator is critical for activation by VP16 in mammalian cells. | 6.77e-05 | 13 | 33 | 2 | 14657022 | |
| Pubmed | 6.77e-05 | 13 | 33 | 2 | 27570068 | ||
| Pubmed | The Deubiquitinase USP37 Regulates Chromosome Cohesion and Mitotic Progression. | 7.04e-05 | 84 | 33 | 3 | 26299517 | |
| Pubmed | Structure, function, and activator-induced conformations of the CRSP coactivator. | 7.89e-05 | 14 | 33 | 2 | 11834832 | |
| Pubmed | 9.10e-05 | 15 | 33 | 2 | 2575583 | ||
| Pubmed | 9.10e-05 | 15 | 33 | 2 | 18418385 | ||
| Pubmed | 1.04e-04 | 16 | 33 | 2 | 10882111 | ||
| Pubmed | Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. | 1.18e-04 | 17 | 33 | 2 | 10235266 | |
| Pubmed | 1.18e-04 | 17 | 33 | 2 | 16109376 | ||
| Pubmed | 1.18e-04 | 268 | 33 | 4 | 33640491 | ||
| Pubmed | 1.32e-04 | 18 | 33 | 2 | 10198638 | ||
| Pubmed | An ARC/Mediator subunit required for SREBP control of cholesterol and lipid homeostasis. | 1.48e-04 | 19 | 33 | 2 | 16799563 | |
| Pubmed | STAGA recruits Mediator to the MYC oncoprotein to stimulate transcription and cell proliferation. | 1.64e-04 | 20 | 33 | 2 | 17967894 | |
| Pubmed | 1.64e-04 | 20 | 33 | 2 | 15340084 | ||
| Pubmed | 1.99e-04 | 22 | 33 | 2 | 11867769 | ||
| Pubmed | 1.99e-04 | 22 | 33 | 2 | 12584197 | ||
| Pubmed | Composite co-activator ARC mediates chromatin-directed transcriptional activation. | 2.18e-04 | 23 | 33 | 2 | 10235267 | |
| Pubmed | Analysis of a lung defect in autophagy-deficient mouse strains. | 2.80e-04 | 26 | 33 | 2 | 24275123 | |
| Pubmed | 2.80e-04 | 26 | 33 | 2 | 34506481 | ||
| Pubmed | Mediator and cohesin connect gene expression and chromatin architecture. | 3.25e-04 | 28 | 33 | 2 | 20720539 | |
| Pubmed | 3.49e-04 | 29 | 33 | 2 | 14638676 | ||
| Pubmed | Characterising the dynamics of placental glycogen stores in the mouse. | 3.49e-04 | 29 | 33 | 2 | 32798765 | |
| Pubmed | 3.53e-04 | 653 | 33 | 5 | 22586326 | ||
| Pubmed | A Role for Sensory end Organ-Derived Signals in Regulating Muscle Spindle Proprioceptor Phenotype. | 4.25e-04 | 32 | 33 | 2 | 30926747 | |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | 4.69e-04 | 695 | 33 | 5 | 23602568 | |
| Pubmed | 4.81e-04 | 34 | 33 | 2 | 15989967 | ||
| Pubmed | DNA Damage Regulates Translation through β-TRCP Targeting of CReP. | 5.09e-04 | 35 | 33 | 2 | 26091241 | |
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 5.34e-04 | 167 | 33 | 3 | 20362541 | |
| Pubmed | 6.33e-04 | 39 | 33 | 2 | 38690566 | ||
| Pubmed | 6.96e-04 | 183 | 33 | 3 | 23956138 | ||
| Pubmed | 7.00e-04 | 41 | 33 | 2 | 8724849 | ||
| Pubmed | Genetic evidence that SOST inhibits WNT signaling in the limb. | 8.43e-04 | 45 | 33 | 2 | 20359476 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q22 | 2.10e-03 | 94 | 33 | 2 | chr14q22 | |
| Cytoband | 1q44 | 2.86e-03 | 110 | 33 | 2 | 1q44 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q44 | 3.85e-03 | 128 | 33 | 2 | chr1q44 | |
| GeneFamily | Glycogen phosphorylases | 5.96e-06 | 3 | 26 | 2 | 437 | |
| GeneFamily | Cyclins|Mediator complex | 1.40e-05 | 33 | 26 | 3 | 1061 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.12e-03 | 206 | 26 | 3 | 682 | |
| GeneFamily | Olfactory receptors, family 2 | 1.14e-02 | 113 | 26 | 2 | 149 | |
| Coexpression | DESCARTES_ORGANOGENESIS_ENDOTHELIAL_CELLS | 1.58e-05 | 272 | 31 | 5 | MM3634 | |
| CoexpressionAtlas | dev gonad_e11.5_M_ReproVasc_Flk_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.27e-07 | 514 | 28 | 8 | gudmap_dev gonad_e11.5_M_ReproVasc_Flk_k4_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.99e-06 | 523 | 28 | 7 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_k3_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_ReproVasc_Flk_top-relative-expression-ranked_1000 | 5.95e-06 | 795 | 28 | 8 | gudmap_dev gonad_e11.5_M_ReproVasc_Flk_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_ReproVasc_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.06e-05 | 444 | 28 | 6 | gudmap_dev gonad_e11.5_F_ReproVasc_Flk_k3_1000 | |
| CoexpressionAtlas | kidney_e15.5_SmlBldVes_Tie2_top-relative-expression-ranked_1000 | 6.88e-05 | 813 | 28 | 7 | gudmap_kidney_e15.5_SmlBldVes_Tie2_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_DevVasOvary_Flk_top-relative-expression-ranked_1000 | 7.09e-05 | 817 | 28 | 7 | gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_top-relative-expression-ranked_1000 | 7.89e-05 | 831 | 28 | 7 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 8.30e-05 | 570 | 28 | 6 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_k3_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000 | 8.83e-05 | 846 | 28 | 7 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_DevVasOvary_Flk_top-relative-expression-ranked_500 | 1.89e-04 | 415 | 28 | 5 | gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_ReproVasc_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 2.20e-04 | 229 | 28 | 4 | gudmap_dev gonad_e11.5_F_ReproVasc_Flk_k4_500 | |
| CoexpressionAtlas | kidney_adult_GlomCapSys_Tie2_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.85e-04 | 245 | 28 | 4 | gudmap_kidney_adult_GlomCapSys_Tie2_k3_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 4.85e-04 | 282 | 28 | 4 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_k4_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.47e-04 | 523 | 28 | 5 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_k4_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_ReproVasc_Flk_top-relative-expression-ranked_1000 | 5.80e-04 | 817 | 28 | 6 | gudmap_dev gonad_e11.5_F_ReproVasc_Flk_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_k-means-cluster#2_top-relative-expression-ranked_500 | 5.97e-04 | 298 | 28 | 4 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_k2_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000 | 7.02e-04 | 847 | 28 | 6 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_1000 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.22e-06 | 169 | 33 | 4 | 987ff79ad563825dd9877ea8ccb536758f8c6700 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-05 | 190 | 33 | 4 | a3c6eec6df052105ab78b7e3c78f94218d5912eb | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.17e-05 | 191 | 33 | 4 | 2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-05 | 192 | 33 | 4 | c07d7b40b2aa4eb27ac85801c014a656e2fd01dc | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-05 | 192 | 33 | 4 | 04f5a2e3dd6beff027b89d66eefdd92036e041af | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-05 | 193 | 33 | 4 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-05 | 193 | 33 | 4 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-05 | 193 | 33 | 4 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-05 | 193 | 33 | 4 | 5122b1ffba42de190061be34ecdc6176f84e56a3 | |
| ToppCell | COVID-19-kidney-Glomerular_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.24e-05 | 194 | 33 | 4 | 660535b492445063d965095a50e1e299ce04c50a | |
| ToppCell | facs-Lung-nan-3m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 195 | 33 | 4 | 7f9b7f15006610ad591063d90e90367bd6083c7f | |
| ToppCell | COVID-19-lung-Capillary_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.29e-05 | 196 | 33 | 4 | ac28e9be288af6f00a841aea4ce4b99aed6b4505 | |
| ToppCell | COVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type | 1.32e-05 | 197 | 33 | 4 | 7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.32e-05 | 197 | 33 | 4 | 6a3c647af41fea923311562575a0d656fbc13cbe | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_capillary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-05 | 198 | 33 | 4 | 1d30a1f73b6d6d838f49751402a29c5ef54aa81f | |
| ToppCell | 10x5'v1-week_12-13-Endothelial|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.35e-05 | 198 | 33 | 4 | 307dd09e6bc820a148f3000f18dae7aedba4be0b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-05 | 198 | 33 | 4 | 92416e65a0dc1a4bf931833407620ea05d362f56 | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.35e-05 | 198 | 33 | 4 | 122215d9288533ad03562cf777e846504863df9a | |
| ToppCell | COVID-19-lung-Capillary_2|lung / Disease (COVID-19 only), tissue and cell type | 1.37e-05 | 199 | 33 | 4 | 793ce71b78a68033ef4419ed571e1dd86b40124f | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-05 | 199 | 33 | 4 | d58edc5f74970bb26d844746184e4bae7c494d6b | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-04 | 152 | 33 | 3 | b61d2f6ee819c8dd4b4b601a8bc8388b1983de58 | |
| ToppCell | droplet-Liver-Npc-21m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-04 | 155 | 33 | 3 | 5d600e159738231d0607ea1a1ebd8510fc241b36 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.03e-04 | 155 | 33 | 3 | d10cf5e922dbd3ca46660404da5aca43f181fc19 | |
| ToppCell | droplet-Liver-Npc-21m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-04 | 160 | 33 | 3 | 85205dc68369d3e04df3460c1f3861ee2dc242a9 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-04 | 163 | 33 | 3 | 8dc0128eeede933537e3bcc5d6ec0322711552f3 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-04 | 163 | 33 | 3 | fd243ca223079033be480a24817a399f281fa4d4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.44e-04 | 165 | 33 | 3 | 88681101d7cf60b99b8ace5d8c0944323b937306 | |
| ToppCell | Endothelial-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 2.52e-04 | 167 | 33 | 3 | 6a03d16165e0b003092c39972928981abd4a75aa | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.61e-04 | 169 | 33 | 3 | a1efc20e34a81ae32f8d278a5486811ade03ef24 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_activated|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.61e-04 | 169 | 33 | 3 | 44d201361eb497222a4972a0e10bac1e05dcfd0a | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass | 2.71e-04 | 171 | 33 | 3 | ce290930385cac35dbd21a5e91cf0f93cf3e99f8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.80e-04 | 173 | 33 | 3 | f193c63cc536d891c9d23043765e320252bb6e65 | |
| ToppCell | Endothelial-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 2.80e-04 | 173 | 33 | 3 | a81992965137195d20fc498f750975303961a828 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-04 | 175 | 33 | 3 | f6e1d7297a4dbb38e1ab4f738d91f0e62abaee69 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.95e-04 | 176 | 33 | 3 | e74ad0db3b05897edcfabeb11008ede2b9eeb638 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.99e-04 | 177 | 33 | 3 | c274fbdc141855ff4581d437d4997c64cc193278 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.99e-04 | 177 | 33 | 3 | 71919b5c9bfa87fdd2cd44dfa057b66ea081be5d | |
| ToppCell | COVID-19-Heart-Lymph_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.99e-04 | 177 | 33 | 3 | 326fde0734ef0d7272693966d346ca479b9d8147 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.99e-04 | 177 | 33 | 3 | c8a51e480b978dc0ded85583261f2c892e085be8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.99e-04 | 177 | 33 | 3 | f5e6df5cafd003bbfbb3b634ee58d0b1e2be5cc7 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-04 | 178 | 33 | 3 | de6cd81e6d58e7687386df163471bf1901b9c0aa | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231|Adult / Lineage, Cell type, age group and donor | 3.04e-04 | 178 | 33 | 3 | c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.04e-04 | 178 | 33 | 3 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | COVID-19-Heart-Lymph_EC|Heart / Disease (COVID-19 only), tissue and cell type | 3.09e-04 | 179 | 33 | 3 | 411620201a860716a8773b92f50f7b94ef34a586 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.15e-04 | 180 | 33 | 3 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | 10x5'-Lung-Myeloid_Dendritic-migDC|Lung / Manually curated celltypes from each tissue | 3.15e-04 | 180 | 33 | 3 | e9e8992deb0beeee5548910e4616e7c990763d99 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.20e-04 | 181 | 33 | 3 | e898ecb8d8f2eb2204225b7b0d665cadcd241139 | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-04 | 181 | 33 | 3 | a53f05c4c47465ee62e353716456bd09ab464b23 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(other)|COVID-19 / group, cell type (main and fine annotations) | 3.20e-04 | 181 | 33 | 3 | 26eb4ee57a70dbf54e096b73129fda9dfda1f6ec | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-04 | 181 | 33 | 3 | fcc94f04dae98b817ec06b282d2e887804d37ae5 | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-endothelial_cells_A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.25e-04 | 182 | 33 | 3 | ea4f6c8f600ffe9f8e0609637b3371a5ac48ca03 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.25e-04 | 182 | 33 | 3 | fd786c88826ad3d5cc5c3d80f8e392d6be1b5267 | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-04 | 183 | 33 | 3 | 709a486154b3157427deb3b8886b63ac39ea42dd | |
| ToppCell | droplet-Liver-nan-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-04 | 183 | 33 | 3 | dc06f19f6f80f4c7f13f1f990c1fe0f91ba64ea7 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.35e-04 | 184 | 33 | 3 | 453295362888c9a59d0e73c7a5b15914c50ff591 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.35e-04 | 184 | 33 | 3 | 15ea746c77785120f69f9ab370fb7eb9b70692f8 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-alveolar_macrophage|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.35e-04 | 184 | 33 | 3 | bd5e8fc453a6393b8778734a2c3c2f1281769bcd | |
| ToppCell | COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 3.41e-04 | 185 | 33 | 3 | f5e14181f45c37d13ee9e017a4c8bc248c353676 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-04 | 185 | 33 | 3 | af86e75096c1812ae27a78405355957ee8043d84 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-Aerocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.41e-04 | 185 | 33 | 3 | 7b3d30a54bec66ca6b0209c86448f4fff97ed75c | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.41e-04 | 185 | 33 | 3 | 673308ca0514a4d3629d61fe91e9d8fb31b72166 | |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(other)|Control / group, cell type (main and fine annotations) | 3.46e-04 | 186 | 33 | 3 | c6075fe84226b370c5139066793844ad33ae2db1 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-04 | 186 | 33 | 3 | 8f77e552e613b6e124443c7f6ef5c1316a5ff8db | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-04 | 186 | 33 | 3 | f1aa0c58336d23bcbe52a59e7af954d20085bdb6 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.46e-04 | 186 | 33 | 3 | 20340a5b5cc7f07386498a4ef937d6fbc9e347c4 | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Monocytic-Nonclassical_monocytes|GI_small-bowel / Manually curated celltypes from each tissue | 3.46e-04 | 186 | 33 | 3 | a16ecf70271894a842925f232009e2623d16947e | |
| ToppCell | E17.5-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.52e-04 | 187 | 33 | 3 | e9aa0a5a0f8e2593de63e83b56b53ae33e60af49 | |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(general)|Control / group, cell type (main and fine annotations) | 3.52e-04 | 187 | 33 | 3 | fb5bcbc8effdbf0e57fcb71aca990a4aa0d65ce8 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.52e-04 | 187 | 33 | 3 | dffa8447c2f3fdacf39a7258c6b4e81a25245041 | |
| ToppCell | E17.5-Endothelial-capillary_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.52e-04 | 187 | 33 | 3 | 61b8a53f29bb8b33c69f680b8359a1143a23999d | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.52e-04 | 187 | 33 | 3 | f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D175|Adult / Lineage, Cell type, age group and donor | 3.52e-04 | 187 | 33 | 3 | 1e52d3d9d664c813d859b5b75e4c07b218818f95 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_immature-endo_immature_arterial1_(12)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.57e-04 | 188 | 33 | 3 | b294d6658e79328bd6fa33223e8c70117ba9789b | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.57e-04 | 188 | 33 | 3 | 73f6ec915934154f435a376cb274b058ff7c5f35 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.57e-04 | 188 | 33 | 3 | aeecbc057dc823f8fcea8a98f18d213bacc7f4db | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+VCAM1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.63e-04 | 189 | 33 | 3 | c121817ddad164e9cfe382c43d0cbc9215508d02 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.63e-04 | 189 | 33 | 3 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 3.63e-04 | 189 | 33 | 3 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.63e-04 | 189 | 33 | 3 | b5fa3a619e3b554a1a45a551c9b6369075fe5615 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.68e-04 | 190 | 33 | 3 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel|Adult / Lineage, Cell type, age group and donor | 3.68e-04 | 190 | 33 | 3 | 91bf3b7e9148589757436a53a4f58e0ebfe54400 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-04 | 190 | 33 | 3 | 8cb950effc449ae59a915132ecc079be54d1acfe | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_EM-B|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.68e-04 | 190 | 33 | 3 | a8d92645950715d2621bf0064b1b2bb4eb400cb3 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations) | 3.68e-04 | 190 | 33 | 3 | 812e11314c76c0179fbe5a9bea29b41ce5cbc93d | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-04 | 190 | 33 | 3 | 17a73a658fb30a4322b31e38db7b240023738f29 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-04 | 190 | 33 | 3 | bb1476b44dd49e1dd52a636a91c4600b6d4fbe2e | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-04 | 190 | 33 | 3 | d180205c70b5ca9bc5a01a2e6cb42fcebc7f630d | |
| ToppCell | IPF-Endothelial-Lymphatic|World / Disease state, Lineage and Cell class | 3.68e-04 | 190 | 33 | 3 | ac029e73da5995221c9b9af551d85e4b835e21d6 | |
| ToppCell | COVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 3.68e-04 | 190 | 33 | 3 | 9fbd92cd6d4683b2490504d29c43cf42020433d4 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-04 | 190 | 33 | 3 | 38a815abf0ac5cac6071737cadc54a514f62d37d | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-04 | 190 | 33 | 3 | 5dfbd064ab1f8a0b18b5975c47f8e79697f3db15 | |
| ToppCell | E17.5-Endothelial|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.68e-04 | 190 | 33 | 3 | 4fb76195ec9d6e0260a628eef6c2b3705acce787 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-04 | 191 | 33 | 3 | 88f91e57a1409bdeb91e9bf47510a6fb998a1bf5 | |
| ToppCell | (3)_MNP-(3)_DC_activated|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.74e-04 | 191 | 33 | 3 | 0353bf797c4ef237b9bb82460c173c7d03cb8883 | |
| ToppCell | E16.5-samps-Endothelial-Immature_fetal_endothelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.74e-04 | 191 | 33 | 3 | 44c596984c6196f6014e0e405dbe5560841e54ff | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma-tip_EC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.74e-04 | 191 | 33 | 3 | cf1a67b7c0d5c0dc5d4d59faf9d9b1a3a1fb00e0 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-04 | 191 | 33 | 3 | 1924af7d8b0a0b892e480a9fd6d874941b0c0b5d | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.74e-04 | 191 | 33 | 3 | a7b18bcf27c38ad2353c239ecb309c80f3ef3359 | |
| ToppCell | E16.5-samps-Endothelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.74e-04 | 191 | 33 | 3 | e7521d4d24f016d4e531cd492a7a69604f0c9e6f | |
| ToppCell | IPF-Endothelial-Lymphatic|IPF / Disease state, Lineage and Cell class | 3.80e-04 | 192 | 33 | 3 | 2496edd8f3a41146d418879de9ee2ccc7857431f | |
| Drug | 1-N-Acetyl-Beta-D-Glucosamine | 2.04e-06 | 2 | 33 | 2 | DB02320 | |
| Drug | 3,5-dimethylphenyl isocyanate | 6.11e-06 | 3 | 33 | 2 | CID000521488 | |
| Drug | 3'-FFdUrd | 6.11e-06 | 3 | 33 | 2 | CID000072260 | |
| Drug | 5-ethyl-4-hydroxy-2-methyl-3(2H)-furanone | 6.11e-06 | 3 | 33 | 2 | CID000093111 | |
| Drug | 2',3',4',5,5'-pentachloro-2-biphenylol | 6.11e-06 | 3 | 33 | 2 | CID000119518 | |
| Drug | adenosine-5'-chloromethylphosphonate | 6.11e-06 | 3 | 33 | 2 | CID000191554 | |
| Drug | AC1L8XK3 | 6.11e-06 | 3 | 33 | 2 | CID000409735 | |
| Drug | N-acetyl-N'-beta-D-glucopyranosyl urea | 6.11e-06 | 3 | 33 | 2 | CID000446801 | |
| Drug | hydan | 6.11e-06 | 3 | 33 | 2 | CID000008360 | |
| Drug | EHMF | 6.11e-06 | 3 | 33 | 2 | CID000033931 | |
| Drug | NSC758405 | 6.11e-06 | 3 | 33 | 2 | CID000003201 | |
| Drug | 3,5-dinitrophenyl phosphate | 6.11e-06 | 3 | 33 | 2 | CID000151920 | |
| Drug | riboflavin tetraacetate | 6.11e-06 | 3 | 33 | 2 | CID000094186 | |
| Drug | 5'-deoxy-5'-fluoro-5'-(methylthio)adenosine | 6.11e-06 | 3 | 33 | 2 | CID000147839 | |
| Drug | pyridoxal phosphoglucose | 6.11e-06 | 3 | 33 | 2 | CID000196007 | |
| Drug | pyridoxal 5'-methylenephosphonate | 6.11e-06 | 3 | 33 | 2 | CID003082249 | |
| Drug | 2,5-dimethyl-3-furanone | 6.11e-06 | 3 | 33 | 2 | CID000085730 | |
| Drug | Plp 5'-mpa | 6.11e-06 | 3 | 33 | 2 | CID003082151 | |
| Drug | 3,5-dinitrophenol | 6.11e-06 | 3 | 33 | 2 | CID000011459 | |
| Drug | glucose-1,2-cyclic phosphate | 6.11e-06 | 3 | 33 | 2 | CID000191723 | |
| Drug | galocitabine | 1.22e-05 | 4 | 33 | 2 | CID000065950 | |
| Drug | uric acid riboside | 1.22e-05 | 4 | 33 | 2 | CID000164933 | |
| Drug | pseudo-dl-glucose | 1.22e-05 | 4 | 33 | 2 | CID000125259 | |
| Drug | 2,5-anhydro-D-mannitol 1-phosphate | 1.22e-05 | 4 | 33 | 2 | CID000189134 | |
| Drug | AC1LAMW2 | 1.22e-05 | 4 | 33 | 2 | CID000491364 | |
| Drug | FdUrd-C8 | 1.22e-05 | 4 | 33 | 2 | CID000094262 | |
| Drug | BCIp4A | 1.22e-05 | 4 | 33 | 2 | CID000192417 | |
| Drug | Mem-CC | 1.22e-05 | 4 | 33 | 2 | CID003081269 | |
| Drug | pyridoxal diphosphate | 1.22e-05 | 4 | 33 | 2 | CID000125696 | |
| Drug | 5-deoxyribose-1-phosphate | 1.22e-05 | 4 | 33 | 2 | CID000135786 | |
| Drug | 3'-chloromethotrexate | 1.22e-05 | 4 | 33 | 2 | CID000097703 | |
| Drug | ingliforib | 1.22e-05 | 4 | 33 | 2 | CID006451325 | |
| Drug | heptulose-2-P | 2.03e-05 | 5 | 33 | 2 | CID000124823 | |
| Drug | m-anisidine | 2.03e-05 | 5 | 33 | 2 | CID000010824 | |
| Drug | indirubin-5-sulphonate | 2.03e-05 | 5 | 33 | 2 | CID005288641 | |
| Drug | 6-FPLP | 2.03e-05 | 5 | 33 | 2 | CID000146246 | |
| Drug | gluconohydroximo-1,5-lactone | 2.03e-05 | 5 | 33 | 2 | CID009576855 | |
| Drug | 2-hydroxypropylphosphonate | 2.03e-05 | 5 | 33 | 2 | CID000441028 | |
| Drug | DHPBU | 2.03e-05 | 5 | 33 | 2 | CID000125914 | |
| Drug | 6-FDPL | 2.03e-05 | 5 | 33 | 2 | CID000129578 | |
| Drug | AC1O3M08 | 2.03e-05 | 5 | 33 | 2 | CID006331955 | |
| Drug | AC1LCUXJ | 2.03e-05 | 5 | 33 | 2 | CID000656425 | |
| Drug | 6-amino-5-bromouracil | 2.03e-05 | 5 | 33 | 2 | CID000080578 | |
| Drug | 5'-isobutylthioinosine | 2.03e-05 | 5 | 33 | 2 | CID003080910 | |
| Drug | etafenone | 2.03e-05 | 5 | 33 | 2 | CID000003275 | |
| Drug | ddEtUrd | 2.03e-05 | 5 | 33 | 2 | CID000451452 | |
| Drug | 5-trifluoromethyl-2'-deoxycytidine | 2.03e-05 | 5 | 33 | 2 | CID000125618 | |
| Drug | 3'-O-methylpyridoxal 5'-phosphate | 2.03e-05 | 5 | 33 | 2 | CID003082179 | |
| Drug | GlcMan | 2.03e-05 | 5 | 33 | 2 | CID000152120 | |
| Drug | U66985 | 2.03e-05 | 5 | 33 | 2 | CID000127224 | |
| Drug | 2,2-dimethyl-3-hydroxybutyric acid | 3.04e-05 | 6 | 33 | 2 | CID000152984 | |
| Drug | CV-araU | 3.04e-05 | 6 | 33 | 2 | CID006441877 | |
| Drug | EdUMP | 3.04e-05 | 6 | 33 | 2 | CID003085112 | |
| Drug | 2-thiothymidine | 3.04e-05 | 6 | 33 | 2 | CID003005944 | |
| Drug | 4-hydroxyacetophenone | 3.04e-05 | 6 | 33 | 2 | ctd:C031335 | |
| Drug | 5'-deoxy-5'-chloroformycin | 3.04e-05 | 6 | 33 | 2 | CID000126430 | |
| Drug | NSC-97433 | 3.04e-05 | 6 | 33 | 2 | CID000001803 | |
| Drug | 5-n-propylthioadenosine | 3.04e-05 | 6 | 33 | 2 | CID000656428 | |
| Drug | AzddCyd | 3.04e-05 | 6 | 33 | 2 | CID000451374 | |
| Drug | 5-Ffdru | 3.04e-05 | 6 | 33 | 2 | CID000065561 | |
| Drug | AR-L57 | 3.04e-05 | 6 | 33 | 2 | CID000156890 | |
| Drug | Carbocyclic Ivdu | 3.04e-05 | 6 | 33 | 2 | CID006439191 | |
| Drug | Carbocyclic Bvdc | 3.04e-05 | 6 | 33 | 2 | CID006438602 | |
| Drug | DNPP | 3.04e-05 | 6 | 33 | 2 | CID000067056 | |
| Drug | 5-chloro-indole-2-carboxylic acid | 3.04e-05 | 6 | 33 | 2 | CID000082693 | |
| Drug | alpha-(fluoromethyl)dehydroornithine | 4.26e-05 | 7 | 33 | 2 | CID006439607 | |
| Drug | 1 Gpt | 4.26e-05 | 7 | 33 | 2 | CID000101247 | |
| Drug | 6-fluoropyridoxal | 4.26e-05 | 7 | 33 | 2 | CID003080803 | |
| Drug | formycins | 4.26e-05 | 7 | 33 | 2 | CID000512867 | |
| Drug | Promonta | 4.26e-05 | 7 | 33 | 2 | CID000108494 | |
| Drug | 2',3'-dideoxy-3'-fluorocytidine | 4.26e-05 | 7 | 33 | 2 | CID000356019 | |
| Drug | heptenitol | 4.26e-05 | 7 | 33 | 2 | CID000188267 | |
| Drug | 5'-methylthioinosine | 4.26e-05 | 7 | 33 | 2 | CID000161214 | |
| Drug | AC1L3372 | 4.26e-05 | 7 | 33 | 2 | CID000108025 | |
| Drug | hydantocidin | 4.26e-05 | 7 | 33 | 2 | CID000125429 | |
| Drug | AC1Q6RZL | 4.31e-05 | 47 | 33 | 3 | CID000001144 | |
| Drug | 6-methylpurine | 5.67e-05 | 8 | 33 | 2 | CID005287547 | |
| Drug | amorphin | 5.67e-05 | 8 | 33 | 2 | CID000122792 | |
| Drug | Etafenone [inn] | 5.67e-05 | 8 | 33 | 2 | CID000066659 | |
| Drug | AC1NUVX5 | 5.67e-05 | 8 | 33 | 2 | CID005461894 | |
| Drug | 5'-iodo-5'-deoxyadenosine | 7.29e-05 | 9 | 33 | 2 | CID000107502 | |
| Drug | 6-benzyl-2-thiouracil | 7.29e-05 | 9 | 33 | 2 | CID000685814 | |
| Drug | Phosphonoserine | 7.29e-05 | 9 | 33 | 2 | DB04522 | |
| Drug | 5'-methylthiotubercidin | 7.29e-05 | 9 | 33 | 2 | CID000188350 | |
| Drug | alpha-maltosyl fluoride | 7.29e-05 | 9 | 33 | 2 | CID000194237 | |
| Drug | 5-Iodoribose 1-phosphate | 7.29e-05 | 9 | 33 | 2 | CID003035973 | |
| Drug | 8-azidoadenosine 5'-monophosphate | 9.10e-05 | 10 | 33 | 2 | CID000124726 | |
| Drug | 2,6-dihydroxypyridine | 9.10e-05 | 10 | 33 | 2 | CID000069371 | |
| Drug | 6-methyluridine | 9.10e-05 | 10 | 33 | 2 | CID000092887 | |
| Drug | UDP-pyridoxal | 9.10e-05 | 10 | 33 | 2 | CID000126789 | |
| Drug | FdUMP | 1.04e-04 | 63 | 33 | 3 | CID000001816 | |
| Drug | 9 Da | 1.11e-04 | 11 | 33 | 2 | CID005287565 | |
| Drug | glucosyl fluoride | 1.11e-04 | 11 | 33 | 2 | CID000150967 | |
| Drug | Cid 11299980 | 1.11e-04 | 11 | 33 | 2 | CID009856533 | |
| Drug | acyclothymidine | 1.33e-04 | 12 | 33 | 2 | CID000072358 | |
| Drug | 5'-deoxypyridoxal | 1.33e-04 | 12 | 33 | 2 | CID000164889 | |
| Drug | BCX-34 | 1.33e-04 | 12 | 33 | 2 | CID000060817 | |
| Drug | AC1L19D1 | 1.33e-04 | 12 | 33 | 2 | CID000000494 | |
| Drug | Ap4U | 1.33e-04 | 12 | 33 | 2 | CID000165888 | |
| Drug | phenylurethane | 1.33e-04 | 12 | 33 | 2 | CID000007591 | |
| Disease | Glycogen Storage Disease | 3.69e-04 | 27 | 31 | 2 | C0017919 | |
| Disease | Ovarian Mucinous Adenocarcinoma | 4.87e-04 | 31 | 31 | 2 | C1335167 | |
| Disease | Hirschsprung Disease | 4.87e-04 | 31 | 31 | 2 | C0019569 | |
| Disease | gait measurement | 5.21e-04 | 150 | 31 | 3 | EFO_0007680 | |
| Disease | retinal vasculature measurement | 2.01e-03 | 517 | 31 | 4 | EFO_0010554 | |
| Disease | obsolete_red blood cell distribution width | 2.47e-03 | 1347 | 31 | 6 | EFO_0005192 | |
| Disease | Cleft palate | 2.54e-03 | 71 | 31 | 2 | HP_0000175 | |
| Disease | neutrophil percentage of leukocytes | 3.65e-03 | 610 | 31 | 4 | EFO_0007990 | |
| Disease | malaria | 5.15e-03 | 102 | 31 | 2 | EFO_0001068 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LNTLIHHCEAVLHLR | 376 | Q9Y297 | |
| LKNLRHQHICQLYHV | 61 | Q14680 | |
| VIHRLTHYDHVLIEL | 776 | Q14566 | |
| HSRLKLYAQVCRHHL | 1496 | Q71F56 | |
| LLHWLLLCSCLHHLY | 36 | Q8N8D9 | |
| ERFLIHIQHHIYSCQ | 421 | Q9Y216 | |
| HHVTCVELFYRLHCL | 891 | Q9Y3R5 | |
| NAVLILLIHCDAHLH | 46 | Q6IEZ7 | |
| HILSHSFCLHQDLLR | 181 | Q9H2C8 | |
| LLEHLHYCQINIIAH | 181 | Q8NGF0 | |
| IVAVLRHYHACLILN | 926 | Q93074 | |
| DHLYVLEHNLHLLIR | 366 | Q9NVC6 | |
| VLRTHLYIHHAIDLA | 971 | Q86XP1 | |
| NAVLILLIHCDAHLH | 46 | Q8NH02 | |
| LVLHLEVRVHCFHYL | 776 | Q96A65 | |
| LHATQLYLLCCHLHS | 141 | Q8WTW3 | |
| LYLLCCHLHSLLQLD | 146 | Q8WTW3 | |
| RLLVHHLCTSHYLDL | 1601 | O43497 | |
| RLHLIYLINDVLHHC | 211 | Q8IWX8 | |
| RLHLVFEYCDHTVLH | 76 | Q00532 | |
| LFKCHIHLRIHELQD | 16 | Q96GE4 | |
| LHRTHDEIVLLHCFL | 161 | Q86W47 | |
| VLQRLCEHLDHALLY | 41 | Q8IWE5 | |
| IRHVYCLHVINHILK | 306 | Q68CQ4 | |
| THISLHCHLVHLLYF | 286 | O15218 | |
| AISYCHKLHVVHRDL | 126 | Q9NRH2 | |
| RNHNTYLHLHLCVCL | 631 | Q14246 | |
| HRQQLFHTLLAIYLH | 711 | Q8WUH2 | |
| IHEYKRQLLNCLHVI | 571 | P11217 | |
| CILHLHYFHDRFLEL | 801 | Q9H5I5 | |
| RHVLIHTNIRAYQCH | 466 | Q8N895 | |
| RILKYHLLLHEIENH | 251 | Q9ULL1 | |
| IHEYKRQLLNCLHVI | 571 | P06737 | |
| HLQLLELLNLCSHYL | 121 | Q96NJ5 | |
| LQFHILRLFHCLHES | 631 | Q86W25 |